The global pharmaceutical company, ViiV Healthcare, commissioned us to co-develop an initiative to improve quality of care for people living with HIV.
The global pharmaceutical company, ViiV Healthcare, commissioned us to co-develop an initiative to improve quality of care for people living with HIV (PLHIV). The resulting Positive Pathways is an ongoing, transformational program to share current practices in HIV care within and across countries.
This unprecedented step in the field of HIV builds on ViiV’s commitment to ensure PLHIV are optimally diagnosed, fully engaged in care and able to achieve successful treatment outcomes, whilst supporting UNAID’s ambitious 90-90-901 HIV treatment target.
Our UK Healthcare and Life Sciences team helped design the programme, conducting primary research with some of the most renowned HIV centres globally and assembling an advisory board of medical experts to review and prioritize findings.
By identifying and analysing current evidence- based approaches to care and sharing them worldwide, we are helping PLHIV lead better quality lives.
We deliver the results that matter.
© 2021 KPMG LLP a UK limited liability partnership and a member firm of the KPMG global organisation of independent member firms affiliated with KPMG International Limited, a private English company limited by guarantee. All rights reserved.
For more detail about the structure of the KPMG global organisation please visit https://home.kpmg/governance.